Physician profile

Alexander S Chen

Internal Medicine · Charlotte, NC

NPI 1972576627

$251.07

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$208.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Siemens Medical Solutions USA, INC. $97.05 2023 Bravos Afterloader System
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $58.90 2023-2024 Lifevest
Abbvie INC. $28.90 2021
Abbott Laboratories $21.23 2024 Proclaim
E.R. Squibb & Sons, L.L.C. $18.23 2024 Eliquis
Pfizer INC. $13.50 2019
Daxor Corporation $13.26 2024 Bva-100

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alexander S Chen

$251.07

in general payments reported 2019-2025

Years
2019-2024
Top company
Siemens Medical Solutions USA, INC.

https://glasscript.com/doctor/846219/alexander-s-chen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.